Spain, 17. October 2017- Last week Biomimetic organized a Coworking day at the national level of Biomimetic; “Another way of understanding laboratory-industry relations”.
This coworking day tries to create an Open Innovation space, bringing together all the agents of the value chain of the sector: suppliers, industrial sector, pharmacy offices, as well as a large international delegation of experts in dermatology technology.
The workday took place at the Príncipe Felipe Research Center, where the company headquarters is located and where also participated more than twenty international experts, who make up the committee of the European project PEPTICAPS, which is developing new dermatological applications based on “smart nanocapsules” within Horizon 2020.
“We are a different laboratory and we want to integrate the entire value chain using the concept of Open Innovation, so today we bring together all the players in our project, pharmacists, research technologists and users, as they are all part of Biomimetic”, says Victor Bazquez, Business Development Biomimetic Cosmetics.
Biomimetic Cosmetics PBT® is a new innovative concept for facial care. The most advanced dermatological technology has enabled us to develop a 100% active formulation, without using excipients or preservatives.
Most clinical studies conclude that hydration is key to a healthier and receptive skin for further treatments. That is why BIOMIMETIC is able to hydrate the skin up to three times more than another premium facial treatment on the market.
Thanks to controlled release of the active, we are able to get a prolonged effect of up to 36 hours, with a single application of four drops.
With 3,7% hyaluronic acid, the highest concentration in the market, we add assets to provide solutions to the main concerns of facial care, creating five treatments for five needs, using the same concept: Moisturizing, Antioxidant, Firming, Anti-aging and Depigmenting.
BIOMIMETIC is also synergistic and complements any subsequent treatment of the facial care routine. It is recommended for sensitive skin thanks to its maximum biocompatibility with the skin cells.
Biomimetic PBT is a registered trademark of Polypeptide Therapeutic Solutions SL, one of five innovative projects launched by the venture capital fund Columbus Venture Partners, which is specialized in medical and biotechnology investments, and has already attracted additional national and foreign currency for more than 100 million euros since its beginning in 2015.